1. Market Research
  2. > Healthcare
  3. > Medical Device
  4. > In Vitro Diagnostics Market Trends

The Molecular Diagnostics (MDx) Market Forecast 2015-2025: Opportunities for Leading Companies

  • October 2015
  • 223 pages
  • Visiongain
Report ID: 2512629


Table of Contents

Please note: The license is valid for 12 months from the date the report is sent.

Report Details
What can be expected from the Molecular Diagnostics market? Which areas are going to grow at the fastest rates? This visiongain report shows you potential revenues to 2025, assessing data, trends, opportunities and prospects there.

Our 223-page report provides 145 tables, charts, and graphs. Discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. You will see financial results, an interview, trends, opportunities, and revenue predictions. There is much opportunity in this fast moving market.

Forecasts from 2015-2025 and other analyses show you commercial prospects
Besides revenue forecasting to 2025, our new study provides you with recent results, growth rates, and market shares. Discover qualitative analyses (including SWOT and Porter’s Five Forces analysis) and commercial developments.

See revenue forecasts for the leading submarkets and indications
How will submarkets perform to 2025? Our study forecasts revenues in the following Molecular Diagnostics (MDx) submarkets:
- Infectious disease testing
- Oncology Testing
- Blood screening
- Genetic testing
- Tissue Typing (HLA)

See revenue forecasts for the leading international markets
How will leading national markets perform to 2025? Our study forecasts revenues in national markets including products, including:
- US
- Japan
- Germany
- France
- Italy
- Spain
- UK
- China
- Brazil
- Russia
- India
- South Korea
- Mexico

Leading companies and potential for market growth
Overall revenue for the Molecular Diagnostics (MDx) market will reach $10.45bn in 2019, our work forecasts. We predict strong revenue growth through to 2025. An ageing population and increasing incidence of chronic diseases, especially cancer, globally will drive sales to 2025.

Our work analyses the key companies in the market. See visiongain’s analysis of 7 leading companies, including these:
- Roche Diagnostics
- Qiagen
- Hologic
- Becton, Dickinson & Company
- bioMérieux
- Cepheid
- Agilent Technologies

A company profile gives you the following information where available:
- Discussion of a company’s activities and outlook
- Analysis of assays and instruments currently on the market as well as pipeline products
- Acquisitions and strategic partnerships

Discover capabilities, progress, and commercial prospects, helping you stay ahead.

What issues will affect Molecular Diagnostics industry?
Our new report discusses issues and events affecting the Molecular Diagnostics market. You will find discussions, including qualitative analyses:
- Highly diverse market needing strong knowledge of national markets
- Unclear regulatory landscape challenging new entrants and major market players alike
- Emerging technologies with the potential to reshape the market

You will see discussions of technological, commercial, and economic matters, with emphasis on the competitive landscape and business outlooks.

How The Molecular Diagnostics (MDx) Market Forecast 2015-2025 report helps you
In summary, our 223-page report gives you the following knowledge:
- Revenue forecasts to 2025 for the Molecular Diagnostics (MDx) market – discover the industry’s prospects, finding promising places for investments and revenues
- Revenue forecasts to 2025 for submarkets in each – discover prospects for leading assays and instrumentation in the following areas: Infectious Disease testing including Chlamydia Trachonomatis (CT), Neisseriae Gonnohroea (NG), Human Papillomavirus (HPV), HIV, Healthcare associated infections (MRSA & Clostridium Difficile) Hepatitis C (HCV) and Respiratory infections (including Influenza and RSV), Oncology Testing and companion diagnostics, Blood Screening, Genetic Testing (including Cystic Fibrosis testing, Thrombophilia testing, inflammatory disease testing and rare disease testing) and Tissue (HLA) typing.
- Revenue forecasts to 2025 for the leading regional markets – US, Japan, EU5, BRIC South Korea and Mexico
- Assessment of 7 leading companies – analysis of Molecular Diagnostic products, revenue, mergers & acquisitions, sales by region and upcoming product releases
- Discussion of what stimulates and restrains companies and the market
- Prospects for established firms and those seeking to enter the market

You will find quantitative and qualitative analyses with independent predictions. You will receive information that only our report contains, staying informed with this invaluable business intelligence.

Information found nowhere else
With our survey you are less likely to fall behind in knowledge or miss opportunity. See how you could benefit your research, analyses, and decisions. Also see how you can save time and receive recognition for commercial insight.

Visiongain’s study is for everybody needing commercial analyses for the Molecular Diagnostics market and leading companies. You will find data, trends and predictions. Please order our report now.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

Amrita helps you find the right report:


The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

Purchase Reports From Reputable Market Research Publishers

Cell-based Assays Market by Product (Reagents, Assay Kits, Microplates, Cell Lines, Service), Application (Research, Drug Discovery, ADME Studies, Toxicology), End User, and Region - Global Forecast to 2022

  • $ 5650
  • Industry report
  • July 2017
  • by MarketsandMarkets

“Cell-based assays market projected to grow at a CAGR of 8.4% during the forecast period” The global cell-based assays market is expected to reach USD 19.92 billion by 2022, at a CAGR of 8.4% from ...

Next-generation Sequencing: Emerging Clinical Applications and Global Markets

  • $ 5501
  • Industry report
  • June 2017
  • by BCC Research

• The global clinical next-generation sequencing (NGS) market reached $2.7 billion in 2016. This market is expected to grow at a compound annual growth rate (CAGR) of 27%, from nearly $3.2 billion in ...

Cell-based Assays: Technologies and Global Markets

  • $ 5501
  • Industry report
  • July 2017
  • by BCC Research

REPORT HIGHLIGHTS • The global market for cell-based assays reached $15.2 billion in 2015. This market is expected to increase from $17.1 billion in 2016 to nearly $28.4 billion in 2021 at a compound ...


Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.